Chargement en cours...
Feature article: LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates diabetic cardiomyopathy by inhibiting inflammation, oxidative stress and apoptosis
Diabetic cardiomyopathy, which refers to the destruction of the structure and function of the heart, is the primary cause of heart failure due to diabetes. LCZ696 is the first angiotensin receptor-neprilysin inhibitor (ARNi) to be used clinically. Our study investigated the role played by LCZ696 dur...
Enregistré dans:
| Publié dans: | Exp Biol Med (Maywood) |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6879777/ https://ncbi.nlm.nih.gov/pubmed/31262190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370219861283 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|